A trial of the antidepressant citalopram has found that in people with Alzheimer’s, the drug may reduce agitation but may also carry risks of worsening cognition and heart problems. The paper is published on Wednesday 19 February in the journal JAMA.
A research team has studied a protein called SORLA in mice, reporting that it could be a promising target for the development of new Alzheimer’s treatments.
Researchers in the US have found that people with two parents affected by Alzheimer’s could show features of the disease in the brain years before any symptoms would show.
Research in France has suggested older women who have high levels of a specific type of oestrogen in their blood may be more likely to develop dementia.
Researchers at four UK universities have been awarded up to £100,000 each in a bid to solve one of the biggest challenges in dementia research, with the goal of helping the early stages of drug development.
Researchers in the US have found that older women with higher levels of omega-3 fatty acids in their blood are also more likely to have larger brains.
A new report into the use of licensed medicines in England has shown the use of drug treatments for Alzheimer’s disease was 48% higher than expected in 2012.
Researchers in London have found men who drink heavily in middle age may have faster memory decline than moderate drinkers, light drinkers or non-drinkers.
A US study has found that a cognitive test designed to be carried out at home may be useful for detecting memory and thinking problems in people over 50.
A clinical trial of 613 people with mild to moderate Alzheimer’s has suggested that a form of vitamin E called alpha tocopherol may help to maintain the ability of people to go about day-to-day tasks.